Effect of Nitric Oxide Delivery Device on Tidal Volume Accuracy During Mechanical Ventilation at Small Tidal Volumes

References

1. 1.↵
   1. Brown KL,
   2. Ridout DA,
   3. Goldman AP,
   4. Hoskote A,
   5. Penny DJ

   . Risk factors for long intensive care unit stay after cardiopulmonary bypass in children. Critical Care Med 2003;31(1):28-33.

   OpenUrlCrossRefPubMedWeb of Science
2. 2.
   1. Pepke-Zaba J,
   2. Higenbottam TW,
   3. Dinh-Xuan AT,
   4. Stone D,
   5. Wallwork J

   . Inhaled nitric oxide as a cause of selective pulmonary vasodilatation in pulmonary hypertension. Lancet 1991;338(8776):1173-1174.

   OpenUrlCrossRefPubMedWeb of Science
3. 3.↵
   1. Miller OI,
   2. Celermajer DS,
   3. Deanfield JE,
   4. Macrae DJ

   . Guidelines for the safe administration of inhaled nitric oxide. Arch Dis Child Fetal Neonatal Ed 1994;70(1):F47-F49.

   OpenUrlAbstract/FREE Full Text
4. 4.↵
   1. Curran RD,
   2. Mavroudis C,
   3. Backer CL,
   4. Sautel M,
   5. Zales VR,
   6. Wessel DL

   . Inhaled nitric oxide for children with congenital heart disease and pulmonary hypertension. Ann Thorac Surg 1995;60(6):1765-1771.

   OpenUrlCrossRefPubMedWeb of Science
5. 5.
   1. Miller OI,
   2. Tang SF,
   3. Keech A,
   4. Pigott NB,
   5. Beller E,
   6. Celermajer DS

   . Inhaled nitric oxide and prevention of pulmonary hypertension after congenital heart surgery: a randomised double-blind study. Lancet 2000;356(9240):1464-1469.

   OpenUrlCrossRefPubMedWeb of Science
6. 6.↵
   1. Stewart DL,
   2. Vogel PA,
   3. Jarrett B,
   4. Potenziano J

   . Effect of inhaled nitric oxide on oxygen therapy, mechanical ventilation, and hypoxic respiratory failure. Minerva Pediatr 2018;70(1):51-58.

   OpenUrl
7. 7.↵
   1. Miller OI,
   2. Celermajer DS,
   3. Deanfield JE,
   4. Macrae DJ

   . Very-low-dose inhaled nitric oxide: a selective pulmonary vasodilator after operations for congenital heart disease. J Thorac Cardiovasc Surg 1994;108(3):487-494.

   OpenUrlPubMedWeb of Science
8. 8.
   1. Mourgeon E,
   2. Gallart L,
   3. Rao GS,
   4. Lu Q,
   5. Law-Koune JD,
   6. Puybasset L,
   7. et al

   . Distribution of inhaled nitric oxide during sequential and continuous administration into the inspiratory limb of the ventilator. Intensive Care Med 1997;23(8):849-858.

   OpenUrlCrossRefPubMedWeb of Science
9. 9.↵
   1. Kirmse M,
   2. Hess D,
   3. Fujino Y,
   4. Kacmarek RM,
   5. Hurford WE

   . Delivery of inhaled nitric oxide using the Ohmeda INOvent Delivery System. Chest 1998;113(6):1650-1657.

   OpenUrlCrossRefPubMedWeb of Science
10. 10.↵
    1. Hiesmayr MJ,
    2. Neugebauer T,
    3. Lassnigg A,
    4. Steltzer H,
    5. Haider W,
    6. Gilly H

    . Performance of proportional and continuous nitric oxide delivery systems during pressure- and volume-controlled ventilation. Br J Anaesth 1998;81(4):544-552.

    OpenUrlCrossRefPubMed
11. 11.↵
    Center for Devices and Radiological Health, Food and Drug Administration. Guidance document for premarket notification submissions for nitric oxide delivery apparatus, nitric oxide analyzer and nitrogen dioxide analyzer. Washington, DC: US Department of Health and Human Services; 2000.
12. 12.↵
    INOmax DSIR plus operation manual. Hampton, NJ: INO Therapeutics LLC; 2014.